LK
Highly rated in
26
conditions

Dr. Lawrence R. Kleinberg

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD
Highly rated in
26
conditions
Specialties:Radiation Oncology
Experience:34 Years
Clinical Trials:Currently Recruiting for 4 Trials
Accepts:New PatientsMedicare
Highly rated in
26
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Lawrence R. Kleinberg's experience treating your condition:
About Dr. Lawrence R. Kleinberg

Lawrence Kleinberg is a Radiation Oncologist in Baltimore, Maryland. Kleinberg has been practicing medicine for over 34 years and is highly rated in 26 conditions, according to our data. His top areas of expertise are Glioblastoma, Brain Tumor, Glioma, Metastatic Brain Tumor, and Gamma Knife Radiosurgery. He is licensed to treat patients in Maryland. Kleinberg is currently accepting new patients.

His clinical research consists of co-authoring 125 peer reviewed articles and participating in 12 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Lawrence R. Kleinberg it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Lawrence R. Kleinberg accepts the following insurance:

  •  Ambetter
Call to see if your plan is accepted.
Locations
Baltimore, MD 21231
Background & Education
Graduate Institution
Yale University School Of Medicine, 1989
Specialties
Radiation Oncology
Licenses
Radiology in MD
Hospital Affiliations
The Johns Hopkins Hospital
Howard County General Hospital
Luminis Health Anne Arundel Medical Center
Sibley Memorial Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials
Preservation of Cognition and Neuropsychiatric Functioning With Corpus Callosum Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases: A Pilot Study
Enrollment Status: Recruiting
Publish Date: September 02, 2022
Intervention Type: Radiation
Study Phase: Not Applicable
A Randomized Phase II Study of Subventricular Zone (SVZ) Irradiation Plus Temozolomide in Newly Diagnosed Glioblastoma Multiforme
Enrollment Status: Recruiting
Publish Date: October 27, 2022
Intervention Type: Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
A Randomized, Open-label Pilot Trial to Evaluate the Safety and Efficacy of Carmustine Wafer in Combination With Retifanlimab and Standard Radiation With or Without Temozolomide in Newly-Diagnosed Adult Subjects With Glioblastoma
Enrollment Status: Recruiting
Publish Date: December 06, 2022
Intervention Type: Drug, Radiation
Study Drugs: RetifanlimabTemozolomide
Study Phase: Phase 1
A Pilot Study of Stereotactic Radiosurgical Hypophysectomy for Intractable Pain From Bone Metastases
Enrollment Status: Recruiting
Publish Date: October 27, 2022
Intervention Type: Radiation
Study Phase: Not Applicable
Phase II Study of Post-Operative Stereotactic Radiosurgery for Solid Tumor Spine Metastases
Enrollment Status: Completed
Publish Date: June 25, 2020
Intervention Type: Radiation
Study Phase: Phase 2
A Pilot Study to Assess Feasibility of 5 Fraction Hypofractionated Stereotactic Radiosurgery Along With Standard Temozolomide as a Lymphocyte Sparing Therapy for Glioblastoma Multiforme
Enrollment Status: Completed
Publish Date: November 19, 2021
Intervention Type: Drug
Study Phase: Early Phase 1
A Phase I Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
Enrollment Status: Active, not recruiting
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: MBG453
Study Phase: Phase 1
Pilot Study of Spectroscopic MRI-Guided, Dose-Escalated Radiation Therapy for Newly-Diagnosed Glioblastoma
Enrollment Status: Active, not recruiting
Publish Date: February 17, 2022
Intervention Type: Drug, Procedure, Radiation
Study Drug: Temozolomide
Study Phase: Phase 2
A Phase II Trial of Low Dose Fractionated Radiation Therapy as a Chemo-Potentiator of Salvage Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma Multiforme
Enrollment Status: Active, not recruiting
Publish Date: June 13, 2022
Intervention Type: Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
Phase I Safety Study of Stereotactic Radiosurgery With Concurrent and Adjuvant PD-1 Antibody Nivolumab in Subjects With Recurrent or Advanced Chordoma
Enrollment Status: Active, not recruiting
Publish Date: October 04, 2022
Intervention Type: Biological, Other, Radiation
Study Drug: Nivolumab
Study Phase: Phase 1
A Pilot Study Using Amide Proton Transfer (APT) Magnetic Resonance Imaging to Distinguish Tumor Bearing Cancerous Tissue From Normal Tissue in Patients With Glioma.
Enrollment Status: Terminated
Publish Date: November 26, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
A Pilot Study of Stereotactic Radiosurgery Combined With Nivolumab in Patients With Newly Diagnosed Melanoma Metastases in the Brain and Spine
Enrollment Status: Completed
Publish Date: November 30, 2021
Intervention Type: Radiation, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 1
View 8 Less Clinical Trials -
125 Total Publications
Evaluation of the Clinical Utility of the Bone Metastases Ensemble Trees for Survival Decision Support Platform (BMETS-DSP): A Case-Based Pilot Assessment.
Journal: JCO clinical cancer informatics
Published: October 28, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
HQ
Dr. Harry C. Quon
Radiation Oncology
Highly rated in
20
conditions
Radiation Oncology

Johns Hopkins Health System

Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins

Baltimore, MD 

Harry Quon is a Radiation Oncologist in Baltimore, Maryland. Quon has been practicing medicine for over 30 years and is highly rated in 20 conditions, according to our data. His top areas of expertise are Laryngeal Cancer, Dry Mouth, Throat Cancer, Prostatectomy, and Endoscopy. He is licensed to treat patients in Maryland and Pennsylvania. Quon is currently accepting new patients.

AV
Dr. Akila N. Viswanathan
Radiation Oncology
Highly rated in
9
conditions
Radiation Oncology

Johns Hopkins Health System

Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins

Baltimore, MD 

Akila Viswanathan is a Radiation Oncologist in Baltimore, Maryland. Viswanathan has been practicing medicine for over 26 years and is highly rated in 9 conditions, according to our data. Her top areas of expertise are Cervical Cancer, Vaginal Cancer, Vulvar Cancer, Vulvectomy, and Gamma Knife Radiosurgery. She is licensed to treat patients in Massachusetts. Viswanathan is currently accepting new patients.

RH
Dr. Russell K. Hales
Radiation Oncology
Highly rated in
14
conditions
Radiation Oncology

Johns Hopkins Health System

Johns Hopkins Bayview Medical Center

4940 Eastern Ave, 
Baltimore, MD 
 2.5 mi

Russell Hales is a Radiation Oncologist in Baltimore, Maryland. Hales has been practicing medicine for over 18 years and is highly rated in 14 conditions, according to our data. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NCSLC), Stent Placement, and Orchiectomy. He is licensed to treat patients in Maryland. Hales is currently accepting new patients.